BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
1-Year Return
36.91%
This Quarter Return
+7.47%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$427M
AUM Growth
-$49.6M
(-10%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-9.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$147M |
| 2 |
Lineage Cell Therapeutics
LCTX
|
+$1.16M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$189M |
Sector Composition
| 1 | Healthcare | 61.68% |
| 2 | Consumer Staples | 34.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $147M | 31.08% |
+1,630,968
| New | +$147M |
|
2
Monster Beverage
MNST
$63.2B
| $147M | 30.98% |
9,594,816
| – | – |
|
3
STAAR Surgical
STAA
$1.37B
| $73.2M | 15.47% |
6,887,095
| – | – |
|
|
4
Lineage Cell Therapeutics
LCTX
$306M
| $43.3M | 9.15% |
17,088,778
+458,434
| +3% | +$1.16M |
|
|
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
| $17.2M | 3.63% |
817,029
| – | – |
|
|
QCOR
6
DELISTED
QUESTCOR PHARMA INC
QCOR
| – | – |
-2,046,660
| Closed | -$189M |
|